Ixchiq
Dec 08, 2023
Valneva’s Ixchiq: First-Ever Chikungunya Vaccine
Over the past 15 years, an estimated 5 million cases of chikungunya have surfaced globally. This virus poses an escalating menace, having affected over half of the world’s nations. Recent cases in Spain, Italy, and France underscore its widespread reach. Additionally, the virus has expanded to new geographical area...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
